Carfilzomib
id:
carfilzomib-267-997408
title:
Carfilzomib
text:
Carfilzomib, sold under the brand name Kyprolis, is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. It was developed by Onyx Pharmaceuticals. The US Food and Drug Administration (FDA) approved it in July 2012.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Carfilzomib
date created:
date modified:
2024-04-07T05:43:06Z
main entity:
{"identifier":"Q15366934","url":"https://www.wikidata.org/entity/Q15366934"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a7/Carfilzomib_structure.svg","width":512,"height":256}
fields total:
13
integrity:
15